Silymarin for Treating Toxic Liver Disease: International Consensus Recommendations

Silymarin for Treating Toxic Liver Disease: International Consensus Recommendations

Chronic liver disease (CLD) is a leading health problem impacting the quality of life globally. China shares a major global burden of CLD—including alcoholic liver disease, nonalcoholic fatty liver disease/metabolic dysfunction-associated fatty liver disease, and drug-induced liver injury, except fo...

Full description

Bibliographic Details
Main Authors: Anton Gillessen, MD, Francesco Angelico, Jun Chen, Lungen Lu, Maria Isabel Lucena, Qingchun Fu, Qing Xie, Raul J. Andrade, Wen Xie, Xiaoyuan Xu, MD, Yanyan Yu, Yi-min Mao, Yuemin Nan
Format: Article
Language:English
Published: Elsevier 2022-01-01
Series:Gastro Hep Advances
Subjects:
Alcoholic Fatty Liver Disease
Nonalcoholic Associated Fatty Liver Disease
Metabolic Dysfunction-Associated Fatty Liver Disease
Drug-Induced Liver Injury
Silymarin
Online Access:http://www.sciencedirect.com/science/article/pii/S277257232200084X

Internet

http://www.sciencedirect.com/science/article/pii/S277257232200084X

Similar Items